2014
DOI: 10.1152/ajpheart.00654.2013
|View full text |Cite
|
Sign up to set email alerts
|

Heparan sulfate side chains have a critical role in the inhibitory effects of perlecan on vascular smooth muscle cell response to arterial injury

Abstract: sulfate side chains have a critical role in the inhibitory effects of perlecan on vascular smooth muscle cell response to arterial injury. Am J Physiol Heart Circ Physiol 307: H337-H345, 2014. First published May 23, 2014; doi:10.1152 doi:10. /ajpheart.00654.2013can is a proteoglycan composed of a 470-kDa core protein linked to three heparan sulfate (HS) glycosaminoglycan chains. The intact proteoglycan inhibits the smooth muscle cell (SMC) response to vascular injury. Hspg2 ⌬3/⌬3 (M⌬3/⌬3) mice produce a mutan… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
10
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(11 citation statements)
references
References 32 publications
1
10
0
Order By: Relevance
“…These mutant mice have impaired angiogenesis, delayed healing after experimental wounding and suppression of tumor growth [ 159 ]. When challenged with flow cessation of the carotid artery, the Hspg 2 Δ3/Δ3 mice show an enhanced intimal hyperplasia and smooth muscle cell proliferation [ 160 , 161 ]. Moreover, during mouse hind-limb ischemia, the HS chains of perlecan are key regulators of the angiogenic response [ 162 ].Collectively, these studies reaffirm the role of HS perlecan in modulating pro-angiogenic factors such as FGF2, VEGFA and PDGF.…”
Section: Pericellular and Basement Membrane Zone Proteoglycansmentioning
confidence: 99%
“…These mutant mice have impaired angiogenesis, delayed healing after experimental wounding and suppression of tumor growth [ 159 ]. When challenged with flow cessation of the carotid artery, the Hspg 2 Δ3/Δ3 mice show an enhanced intimal hyperplasia and smooth muscle cell proliferation [ 160 , 161 ]. Moreover, during mouse hind-limb ischemia, the HS chains of perlecan are key regulators of the angiogenic response [ 162 ].Collectively, these studies reaffirm the role of HS perlecan in modulating pro-angiogenic factors such as FGF2, VEGFA and PDGF.…”
Section: Pericellular and Basement Membrane Zone Proteoglycansmentioning
confidence: 99%
“…These two HSPG differ in regard to their localization: agrin was predominantly found in the subendothelial BM and perlecan was found in the BM underneath endothelial cells and around smooth muscle cells [4,206]. On the structural cells of the vessel wall, perlecan with its heparan sulfate chains may exert different functions, as it is reported to induce angiogenesis [207], yet to inhibit smooth muscle cell proliferation [208,209]. Additionally, PDGF-BB, one of the major factors driving vascular remodeling, contains a retention motif that allows binding to perlecan, thereby establishing a growth factor/morphogen gradient [210,211].…”
Section: Bm Hspgs In Phmentioning
confidence: 99%
“…Given the importance of laminins for a number of cellular functions, this provides crucial data for future attempts to recreate the aortic valve through tissue engineering. The presence or absence of laminins, and other ECM components such as perlecan, [51][52][53][54] heparan sulfate, 16 and fibronectin 4,55 is bound to affect the viability of tissueengineered heart valve grafts, but other factors that influence graft viability also need to be considered. Aside from a lack of appropriate ECM components, structural deterioration of tissue-engineered heart valve grafts may be due to (i) immunogenicity, 56 (ii) thrombogenicity, 57 or (iii) incomplete or inappropriate valvular endothelial or interstitial cell repopulation.…”
Section: Discussionmentioning
confidence: 99%